Search Results 1801-1810 of 21378 for anti-TNF drugs

1. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Has any unresolved toxicity grade > 1 from previous anti-cancer therapy. Subject use of immunosuppressive medication within 14 days before the Cycle 1 Day 1:.

2. Melanoma - Care at Mayo Clinic

   Advanced diagnosis and treatment. Mayo Clinic doctors have access to the latest in diagnostic methods and treatment innovations to improve care for people with ...

3. Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer - Mayo Clinic

   Participation eligibility · Cisplatin ineligibility is defined as meeting one of the following criteria: · Anti PD-1/PD-L1 therapy administered as part of ...

4. A Study to Evaluate the Use of Adipose-derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis - Mayo Clinic

   Patients receiving treatment with hematopoietic growth factors or anti-vasculogenesis or anti-angiogenesis treatment (e.g., anti-VEGF). Patients requiring ...

5. Mayo Clinic Minute: Treatment for uterine fibroids without surgery

   Elizabeth Stewart, a Mayo Clinic gynecologist and researcher, recently published a review on these approved fibroid medications. They are called oral ...

6. Mycophenolate Mofetil (Oral Route) Proper Use - Mayo Clinic

   If you have questions, talk with your doctor about the best times to use your medicines. Dosing. The dose of this medicine will be different for different ...

7. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   Patient with aggressive NHL must have received prior therapy - at a minimum: Anti-CD20 monoclonal antibody unless tumor is CD20 negative; and; An ...

8. Phentermine And Topiramate (Oral Route) Precautions - Mayo Clinic

   You will also be required to have a pregnancy test every month during your treatment. If you miss a period while you are using this medicine, tell your doctor ...

9. Zonisamide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

10. Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant - Mayo Clinic

    ... anti-human leukocyte antigen (HLA) antibody specific for their deceased donor. It is our hypothesis that blockade of terminal complement activation with ...